| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_066042e528bd8815a596c06ce8fb3fdb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-042 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775 |
| filingDate |
2012-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d82cab858035146bf675e1920e908d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9c1fef02f9103ce610b047622ba568d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e700832897560b202ab317b4fe2b4c35 |
| publicationDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2627173-C2 |
| titleOfInvention |
Lipoprotein complexes and their preparation and application |
| abstract |
FIELD: pharmacology. n SUBSTANCE: presented method comprises: (a) cooling of initial suspension containing lipid component and protein component from the temperature in the first temperature range to the temperature in the second temperature range; (b) heating of the cooled suspension of stage (a) from the temperature in the second temperature range to the temperature in the first temperature range; (c) cooling of the mentioned heated suspension of stage (b) from the temperature in the first temperature range to the temperature in the second temperature range; and (d) repeating of the stages (b) and (c) at least once to prepare lipoprotein complexes. n EFFECT: presented inventions can be used to prepare homogeneous pharmaceutically acceptable drugs with less risk of adverse events due to contaminations during their use. n 51 cl, 59 dwg, 19 tbl, 9 ex |
| priorityDate |
2011-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |